• News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter
  • Voices
  • Not To Miss
  • FDA Approvals
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Celebrities and Cancer
  • Cancer Types
  • Radiotherapy
  • Science
  • Trial Updates
  • ASCO
  • ESMO
  • ESO
  • MASCC
  • Cancer Center Near Me
  • Immune Oncology
  • Oncologist Near Me
  • OncoDaily Party 2025
  • Childhood Cancer
  • Health Policy
  • Hall of Fame
  • OncoIndustry
  • Public Health
  • Oncology Tech
  • Blog Posts
  • BIGR
  • Global Cancer Movement
  • History
  • Oncolibrary
  • OncoThon 2025
  • Yvonne Award 2025
Double Left Left Mar / 2026 Right Double Right
March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Feb    
OncodailyJournal CancerWorld OncoDaily IO OncoDaily GI Hemostasis Today Fertility News
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Voices
  • Not To Miss
  • FDA Approvals
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
  • News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter

60 questions about SCLC with Dr. Greg Kalemkerian Part 2

Roquefort Therapeutics Acquires Global Rights to TACC3 Inhibitor AO-252 in £31.9M Deal, Pivoting to Clinical-Stage Oncology

15 Posts Not To Miss from ESGO 2026

MSK Awards and Appointments January 2026

Rezatapopt Shows Early Activity in TP53 Y220C–Mutated Solid Tumors

15 Posts Not To Miss From ASCO GU 2026

LITESPARK-022 Update: Adjuvant Belzutifan + Pembrolizumab in High-Risk Clear Cell Renal Cell Carcinoma

Guru Sonpavde: Early Success With EV and FGFR Inhibitor in Bladder Cancer Patients

OncoCalendar

6 events found.

Sharing Progress in Cancer Care

« All Events
Phone +41 91 820 09 68
Email info@spcc.net
Website https://www.spcc.net/contacts/

Events from this organizer

Today
  • November 2024

  • Tue 5
    Lung cancer highlights from the ESMO Congress 2024 by SPCC

    Lung cancer highlights from the ESMO Congress 2024 by SPCC

    Nov 5, 2024 • 6:00 PM

    Lung cancer highlights from the ESMO Congress 2024 by SPCC will take place at November 5th, 2024. It is a live webinar by SPCC which will be futuring Aleksandra Filipovic, Alfredo Addeo, Christian Rolfo. The landscape of treatment for thoracic malignancies has undergone significant and rapid advancements in recent years. New therapies, including targeted treatments, […]

  • Wed 27
    Overview and clarification of the current HR+ HER2- EBC treatment landscape by SPCC

    Overview and clarification of the current HR+ HER2- EBC treatment landscape by SPCC

    Nov 27, 2024 • 6:00 PM - 7:30 PM

    Overview and clarification of the current HR+ HER2- EBC treatment landscape by SPCC will be held at November 27, 2024. It is a live webinar by SPCC and the event will feature presentations on the latest advancements in breast cancer treatment, with an introduction by Fiorita Poulakaki from Greece. Michael Gnant from Austria will discuss […]

  • December 2024

  • Tue 17
    SPCC

    Immunotherapy and GI cancer. Learnings from the ESMO Congress 2024, ESMO Immuno-Oncology Congress 2024 and Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 by SPCC

    Dec 17, 2024 • 6:00 PM - 7:00 PM

    Immunotherapy and GI cancer. Learnings from the ESMO Congress 2024, ESMO Immuno-Oncology Congress 2024 and Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 by SPCC will be held at December 17th, 2024. Join this Live Webinar on advancements in gastrointestinal (GI) cancer care, featuring experts Van Cutsem Eric, Neuzillet Cindy, and Ruiz-Garcia Erika. The […]

  • Wed 18
    Haemato-oncology highlights from 66th ASH Annual Meeting by SPCC

    Haemato-oncology highlights from 66th ASH Annual Meeting by SPCC

    Dec 18, 2024 • 6:00 PM - 7:00 PM

    Haemato-oncology highlights from 66th ASH Annual Meeting by SPCC will be held at December 18, 2024. This live webinar serves as a crucial platform for oncologists to stay informed about the latest research and breakthroughs in haemato-oncology, with key highlights from the ASH meeting. By providing insights into recent advancements, the webinar aims to deepen […]

  • Thu 19
    Breast cancer highlights from the San Antonio Breast Cancer Symposium 2024 by SPCC

    Breast cancer highlights from the San Antonio Breast Cancer Symposium 2024 by SPCC

    Dec 19, 2024 • 6:00 PM - 7:00 PM

    Breast cancer highlights from the San Antonio Breast Cancer Symposium 2024 by SPCC will be held at December 19, 2024. This live webinar will start with an introduction by Nadia Harbeck from Germany, setting the stage for the evening's discussions. Shani Paluch-Shimon from Israel will then present the latest updates on Early Breast Cancer (EBC) […]

  • January 2025

  • Wed 15
    CACA

    2025 CACA-OncoDaily-SPCC Cancer Summit: Bridging Continents

    Jan 15, 2025 • 2:00 PM - 4:00 PM
    Virtual Event

    The Cancer Summit, organized by the China Anti-Cancer Association (CACA), OncoDaily, Sharing Progress in Cancer Care (SPCC), and the World Association for Integrative Oncology (WAIO), will take place on January […]

  • Today
  • Next Events
  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live
  • Export .ics file
  • Export Outlook .ics file
CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

LinkedIn X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
About Privacy Policy Editorial Policy Cookie Policy Disclaimer
Crafted by Matemat
Oncology OncoDaily cancer fight against cancer Global fight against cancer Breast Cancer cancer care ASCO Lung cancer Cancer research Headlines ESMO MD Anderson Cancer Center immunotherapy NSCLC cancer treatment cancer awareness Research colorectal cancer ASCO24 Childhood Cancer clinical trials prostate cancer FDA AACR UICC Dana-Farber Cancer Institute American Cancer Society European Cancer Organisation SIOP chemotherapy Myeloma Robert Orlowski NCI Vivek Subbiah National Cancer Institute American Society of Clinical Oncology Myeloma Paper of the Day Pancreatic Cancer healthcare Paolo Tarantino AI radiation oncology cervical cancer IASLC WHO ASCO25 Zainab Shinkafi-Bagudu multiple myeloma Memorial Sloan Kettering Cancer Center

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}